Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X8VL
|
|||
| Drug Name |
Isoxazoline derivative 3
|
|||
| Synonyms |
PMID26413912-Compound-87
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
INFINITY PHARMACEUTICALS, INC. BEHNKE, Mark, L. CASTRO, Alfredo, C. CHAN, Lawrence, K. EVANS, Catherine, A. GRENIER, Louis GROGAN, Michael, J. LEBLANC, Yves LIU, Tao PELUSO, Stephane SNYDER, Daniel, A. TIBBITTS, Thomas, T
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H16N2O3
|
|||
| Canonical SMILES |
C1C(ON=C1OC2=CC=C(C=C2)C#N)C3=CC=C(C=C3)OC4=CC=CC=C4
|
|||
| InChI |
1S/C22H16N2O3/c23-15-16-6-10-20(11-7-16)26-22-14-21(27-24-22)17-8-12-19(13-9-17)25-18-4-2-1-3-5-18/h1-13,21H,14H2/t21-/m1/s1
|
|||
| InChIKey |
QRYXBMPYZGEVSA-OAQYLSRUSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.